ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
Kim M, Tsinalis D, Franz S, Binet F, Gürke L, Mihatsch M, Steiger J, Thiel G, Dickenmann M. ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial. Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7.
Jan 1, 2008
ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: a prospective randomized pilot trial
Jan 1, 2008
Annals of transplantation : quarterly of the Polish Transplantation Society 2008; 13:21-7
Kim Min Jeong, Tsinalis Dimitrios, Franz Stefan, Binet Françoise-Isabelle, Gürke Lorenz, Mihatsch Michael J, Steiger Jürg, Thiel Gilbert, Dickenmann Michael
more